Wang, Z., Min, X., Xiao, S. H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., Thibault, S., & Walker, N. (2013). Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure, 21(5). https://doi.org/10.1016/j.str.2013.02.025

Pyne, N. J., Tonelli, F., Lim, K. G., Long, J. S., Edwards, J., & Pyne, S. (2012). Sphingosine 1-phosphate signalling in cancer. Biochemical Society Transactions, 40(1), 94–100. https://doi.org/10.1042/BST20110602

Vettorazzi, M., Angelina, E., Lima, S., Gonec, T., Otevrel, J., Marvanova, P., Padrtova, T., Mokry, P., Bobal, P., Acosta, L. M., Palma, A., Cobo, J., Bobalova, J., Csollei, J., Malik, I., Alvarez, S., Spiegel, S., Jampilek, J., & Enriz, R. D. (2017). An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors. European Journal of Medicinal Chemistry, 139. https://doi.org/10.1016/j.ejmech.2017.08.017

Capra, J. A., & Singh, M. (2007). Predicting functionally important residues from sequence conservation. Bioinformatics, 23(15). https://doi.org/10.1093/bioinformatics/btm270

Valdar, W. S. J. (2002). Scoring residue conservation. Proteins: Structure, Function and Genetics, 48(2). https://doi.org/10.1002/prot.10146

Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016). ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Research, 44(W1). https://doi.org/10.1093/NAR/GKW408

Zhao, X., Lu, Z., Na, Y., & and Shu, M. (n.d.). Identification of potential SPHK1 inhibitors based on structural optimization by molecular simulation. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2025.2479849

Alkafaas, S. S., Elsalahaty, M. I., Ismail, D. F., Radwan, M. A., Elkafas, S. S., Loutfy, S. A., Elshazli, R. M., Baazaoui, N., Ahmed, A. E., Hafez, W., Diab, M., Sakran, M., El-Saadony, M. T., El-Tarabily, K. A., Kamal, H. K., & Hessien, M. (2024). The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target. In Cancer Cell International (Vol. 24, Issue 1). https://doi.org/10.1186/s12935-024-03221-8

 Chen, H., Haddadi, N., Zhu, X., Hatoum, D., Chen, S., Nassif, N. T., Lin, Y., & McGowan, E. M. (2022). Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform. Journal of Oncology, 2022. https://doi.org/10.1155/2022/2250407

Jin, L., Zhu, J., Yao, L., Shen, G., Xue, B. xin, & Tao, W. (2023). Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth. Cell Death and Disease, 14(8). https://doi.org/10.1038/s41419-023-06023-4